Balance Sheet
Cash Flow Statement
AcquisitionsBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Gains from Investment Securities (2017 - 2025)

Historic Gains from Investment Securities for ENvue Medical (FEED) over the last 11 years, with Q2 2025 value amounting to $4411.0.

  • ENvue Medical's Gains from Investment Securities rose 11017500.0% to $4411.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $4411.0, marking a year-over-year increase of 11017500.0%. This contributed to the annual value of -$1000.0 for FY2024, which is 10976.18% down from last year.
  • ENvue Medical's Gains from Investment Securities amounted to $4411.0 in Q2 2025, which was up 11017500.0% from $45059.0 recorded in Q1 2025.
  • In the past 5 years, ENvue Medical's Gains from Investment Securities registered a high of $180000.0 during Q1 2021, and its lowest value of -$5000.0 during Q4 2024.
  • For the 5-year period, ENvue Medical's Gains from Investment Securities averaged around $90828.5, with its median value being $133000.0 (2022).
  • In the last 5 years, ENvue Medical's Gains from Investment Securities crashed by 14880.91% in 2024 and then soared by 11017500.0% in 2025.
  • Quarter analysis of 5 years shows ENvue Medical's Gains from Investment Securities stood at $127000.0 in 2021, then increased by 16.24% to $147619.0 in 2022, then plummeted by 93.06% to $10244.0 in 2023, then tumbled by 148.81% to -$5000.0 in 2024, then surged by 188.22% to $4411.0 in 2025.
  • Its Gains from Investment Securities stands at $4411.0 for Q2 2025, versus $45059.0 for Q1 2025 and -$5000.0 for Q4 2024.